Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | CCKBR | P32239 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6177709 | 0.84 | CCKBR (0.43) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL6176620 | 0.84 | CCKBR (0.42) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL6181018 | 0.80 | CCKBR (0.43) | CCKBR | |
| SCHEMBL6178095 | 0.78 | MAPT (0.42) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL6180308 | 0.77 | CCKBR (0.69) | CCKBR | |
| SCHEMBL9690349 | 0.76 | CCKBR (0.52) | CCKBR | |
| SCHEMBL9692280 | 0.76 | CCKBR (0.55) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL30044625 | 0.76 | CCKBR (0.60) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL5672901 | 0.76 | CCKBR (0.60) | CCKBRMAPTSMN1; SMN2 | |
| SCHEMBL5698825 | 0.76 | CCKBR (0.60) | CCKBRMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |